VAERS 1481909
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN531
- Staat
- NY
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 18.07.2021
- Impfdatum
- 22.02.2021
- Beginn
- 06.03.2021
- Tage bis Beginn
- 12,0
- Dosis
- 2
- Route/Site
- - / LA
Symptomtext
Mid-cycle bleeding resembling a full flow full duration (5 day) period on day 14 of my cycle.; This is a spontaneous report from a contactable other healthcare professional (patient). A 43-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 22Feb2021 (at the age of 43-years-old) (Batch/Lot Number: EN531) as single dose for COVID-19 immunisation. Medical history included covid prior vaccination. The patient had no known allergies. There were no concomitant medications. The patient did not receive any other vaccine in four weeks and other medications in two weeks. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in Arm Left on 01Feb2021 (at the age of 43-years-old) (Batch/Lot Number: EL3248) for COVID-19 immunisation. Since 06Mar2021 09:00 AM, the patient had mid-cycle bleeding resembling a full flow full duration (5 day) period on day14 of her cycle. The patient did not receive treatment for AE. The patient had not tested covid post vaccination. Outcome of the event was unknown. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intermenstrual bleeding
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: COVID-19
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -